Cargando…

Intra‐Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing

Detalles Bibliográficos
Autores principales:	Burt, T, Noveck, RJ, MacLeod, DB, Layton, AT, Rowland, M, Lappin, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593170/ https://www.ncbi.nlm.nih.gov/pubmed/28419765 http://dx.doi.org/10.1111/cts.12464

Ejemplares similares

Intra‐Target Microdosing – A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans
por: Burt, T, et al.
Publicado: (2017)

Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
por: Burt, T, et al.
Publicado: (2016)

ITM Probe: analyzing information flow in protein networks
por: Stojmirović, Aleksandar, et al.
Publicado: (2009)

Nausea and Vomiting Remedies in Iranian Traditional Medicine (ITM)
por: ALIASL, Fatemeh, et al.
Publicado: (2015)

The Challenges of Clinical Researches in Iranian Traditional Medicine (ITM)
por: Tabarrai, Malihe, et al.
Publicado: (2016)

Itm2a Expression in the Developing Mouse First Lower Molar, and the Subcellular Localization of Itm2a in Mouse Dental Epithelial Cells
por: Kihara, Makiko, et al.
Publicado: (2014)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

Microdosing: Concept, Application and Relevance
por: Tewari, Tushar, et al.
Publicado: (2010)

Asking questions of psychedelic microdosing
por: Cameron, Lindsay P
Publicado: (2021)

First identification of ITM2B interactome in the human retina
por: Wohlschlegel, J., et al.
Publicado: (2021)

A systematic study of microdosing psychedelics
por: Polito, Vince, et al.
Publicado: (2019)

The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020)

ITM Motive set up to manage UK portfolio of hydrogen stations
Publicado: (2020)

The Burden of the “False‐Negatives” in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures
por: Burt, T, et al.
Publicado: (2017)

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
por: Rootman, Joseph M., et al.
Publicado: (2021)

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Exploring ITM2A as a new potential target for brain delivery
por: Cegarra, Céline, et al.
Publicado: (2022)

Phase 0 - Microdosing strategy in clinical trials
por: Rani, P. Usha, et al.
Publicado: (2008)

Psychedelic microdosing benefits and challenges: an empirical codebook
por: Anderson, Thomas, et al.
Publicado: (2019)

Earlier intra-arrest transnasal cooling may be beneficial
por: Castren, M, et al.
Publicado: (2011)

Intra-Venous Injections in the 18th Century, and Earlier
Publicado: (1918)

Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Farm and Livelihood Characteristics After ITM Vaccination Against East Coast Fever in Tanzania
por: Teufel, Nils, et al.
Publicado: (2021)

Cross-Countries Comparison Toward Digital Currency Acceptance: Integrating UTAUT2 Into ITM
por: Lin, Xin, et al.
Publicado: (2022)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022)

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
por: Pasquale, Louis R, et al.
Publicado: (2018)

Interaction Between ITM2B and GLUT9 Links Urate Transport to Neurodegenerative Disorders
por: Mandal, Asim K., et al.
Publicado: (2019)

Blood assays for earlier detection of cancers
por: Pardee, AB, et al.
Publicado: (2000)

Disease Detection by Ultrasensitive Quantification of Microdosed Synthetic Urinary Biomarkers
por: Warren, Andrew D., et al.
Publicado: (2014)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Microbial population dynamics under microdoses of the essential oil arborvitae
por: McGregor, Rhegan C., et al.
Publicado: (2019)

Powerful substances in tiny amounts: An interview study of psychedelic microdosing
por: Johnstad, Petter Grahl
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health
por: Ryan, Rebecca S., et al.
Publicado: (2023)

Subjective and Objective Measurements of the Facial Effects of Microdoses of Botulinum Toxin
por: Hexsel, Doris, et al.
Publicado: (2023)

ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial
por: Redfern, Julie, et al.
Publicado: (2019)

Lnc-ITM2C-1 and GPR55 Are Proviral Host Factors for Hepatitis C Virus
por: Hu, Pan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ol00rujooiipnfpuc7103s986